Immunoblot analysis using Annexin 5 and PCNA antibodies showed that pan PPAR-iMSC-EVs treatment decreased apoptotic cell death, whereas it promoted the proliferation of hepatocytes in the NASH liver (Fig. 8D). Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.